Aggressive therapy greatest for several acute myeloid leukemia patients A new study suggests that acute leukemia individuals whose cancer cells show a genetic switch that usually predicts a swift come back of the disease following remission may stay disease-free much longer when given aggressive therapy. The findings connect with people with acute myeloid leukemia whose tumor cells have normal-searching chromosomes and a gene mutation called MLL-PTD. Typically, these AML individuals responded following treatment with old standard therapies poorly, relapsing within a 12 months often rx tablets .
The selection is a follow-up to an initial successful co-operation with Agfa Health care for the advancement and roll-out of the hospital’s first RIS/PACS in 2006. The task will support The First Affiliated Hospital’s ambitions to bring its facility nearer to a fully digital environment. The new collaboration with Agfa Health care, which is prepared to start in this month, will expand the existing RIS/PACS solution to also service the different picture intensive departments outside Radiology, including Trauma and Cardiology. In a final phase, the complete RIS/PACS solution will become integrated with the hospital’s Hospital Info System , permitting the distribution of diagnostic info to all clinical departments within the institution. When completed, the phase two RIS/PACS projects shall provide clinicians with a complete overview of available diagnostic data, and a information and remote discussion technology platform, allowing the hospital to boost its medical support and management efficiency.